Scott Steele Steps In as FDA’s Interim CBER Head After Marks’ Departure

Following the dramatic late-night resignation of Peter Marks last Friday, Steele, a senior advisor to the division, takes the reins in a department inside an agency beset by cuts, layoffs, and confusion.

Scroll to Top